CertiPath and ZEVA Acquire SAFE-BioPharma

May 31, 2019

CertiPath and ZEVA jointly acquired SAFE-BioPharma, a provider of high-assurance digital identity and cryptography standards for the pharmaceutical, biotechnology, and healthcare industries. The buyers intend to refresh and expand SAFE-BioPharma's policies, specifications, and services to strengthen digital identity trust across regulated health and life-science organizations.

Buyers
CertiPath, ZEVA
Targets
SAFE-BioPharma
Industry
Cybersecurity
Location
Virginia, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.